ArticleThe journal of headache and pain2025
Neuroimaging epicenters and the related neurobiological signatures in patients with postherpetic neuralgia.
Article in The journal of headache and pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effect of Electroacupuncture on Postherpetic Neuralgia: A Randomized Clinical Trial.JAMA neurology · 2026Trial
- Development and validation of a machine learning model for predicting postherpetic neuralgia risk.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundPostherpetic neuralgia (PHN) is a typical neuropathic pain syndrome and frequently involves central and peripheral neuropathic signs. Considering the long-term pain conditions, pain, sleep disturbance, and mental disorders often create a self-perpetuating vicious cycle, wherein each factor exacerbates the others. The current understanding of the complex pathology of PHN remains limited, which hinders the clinical treatment of its pain symptoms.
methodsTo explore the neurobiological alterations linked with PHN, we utilized a novel method, the neuroimaging epicenter, to identify the candidate sites of its pathological processes and further investigated the related neurobiological signatures by exploring the associations of gene expression, neurotransmitter receptors/transporters distribution, and functional activity.
resultsAs the primary epicenter, the ventroanterior thalamus is suggested to be the candidate region involved in the onset of the PHN neuropathophysiology. Furthermore, neuroimaging epicenters are related with clinical symptoms including pain, sleep disturbance, and anxiety and depression levels. And neuroimaging epicenters are correlated with downstream pain activity, upstream neurotransmitter receptors/transporters distribution mainly including opioid and acetylcholine, and gene expression maps.
conclusionswe used a novel method to identify the ventroanterior thalamus as the potential epicenter of PHN, supported by the neurobiological interpretations. The presence of epicenters highlights that there may exist a reliable neuroimaging biomarker, which offers potential treatment targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.